Literature DB >> 33358896

Risk Factors for Frailty in Critical Care Survivors: A secondary analysis.

Jiyeon Kang1, Yeon Jin Jeong2, Jun Hee Jang2, Minju Lee3.   

Abstract

OBJECTIVES: The purpose of this study was to investigate the prevalence of frailty and its risk factors among critical care survivors who were discharged after receiving treatment in an intensive care unit.
METHODS: This was a secondary analysis using data from a methodological study conducted between June and August 2018. The sample included 494 adults who had been admitted to the intensive care unit for more than 48 hours within a year. Only post-intensive care frailty was evaluated using the Kihon Checklist. The sociodemographic and intensive care-related risk factors for frailty were analysed using multivariate logistic regression.
RESULTS: The prevalence of frailty in the sample was 65.8%. The risk factors for frailty were female sex (adjusted odds ratio [aOR] = 1.68, 95% CI: 1.02-2.78), aged 70 years or older (aOR = 4.16, 95% CI: 2.00-8.65), unemployment (aOR = 2.41, 95% CI: 1.39-4.17) and longer ICU days (aOR = 2.29, 95% CI: 1.35-3.91). Analysis of differences in risk factors according to sex revealed that risk factors for frailty were unemployment and longer ICU length of stay for male and older age for female.
CONCLUSION: Health care providers should be aware of frailty risk factors in female and male patients and provide patient-specific interventions for preventing frailty.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  Frailty; Intensive care units; Prevalence; Risk factors; Survivors

Year:  2020        PMID: 33358896     DOI: 10.1016/j.iccn.2020.102981

Source DB:  PubMed          Journal:  Intensive Crit Care Nurs        ISSN: 0964-3397            Impact factor:   3.072


  1 in total

1.  Serum Inflammatory Factors and Oxidative Stress Factors Are Associated With Increased Risk of Frailty and Cognitive Frailty in Patients With Cerebral Small Vessel Disease.

Authors:  Lei Mu; Limin Jiang; Juan Chen; Mei Xiao; Wei Wang; Peipei Liu; Jialing Wu
Journal:  Front Neurol       Date:  2022-01-06       Impact factor: 4.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.